Nasal high flow, but not supplemental O-2, reduces peripheral vascular sympathetic activity during sleep in COPD patients
Carregando...
Citações na Scopus
5
Tipo de produção
article
Data de publicação
2018
Título da Revista
ISSN da Revista
Título do Volume
Editora
DOVE MEDICAL PRESS LTD
Autores
Citação
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, v.13, p.3635-3643, 2018
Resumo
Introduction: Patients with COPD have increased respiratory loads and altered blood gases, both of which affect vascular function and sympathetic activity. Sleep, particularly rapid eye movement (REM) sleep, is known to exacerbate hypoxia and respiratory loads. Therefore, we hypothesize that nasal high flow (NHF), which lowers ventilatory loads, reduces sympathetic activity during sleep and that this effect depends on COPD severity. Methods: We performed full polysomnography in COPD patients (n=17; FEV1, 1.6 +/- 0.6 L) and in matched controls (n=8). Participants received room air (RA) at baseline and single night treatment with O-2 (2 L/min) and NHF (20 L/min) in a random order. Finger pulse wave amplitude (PWA), a measure of vascular sympathetic tone, was assessed by photoplethysmography. Autonomic activation (AA) events were defined as PWA attenuation >= 30% and indexed per hour for sleep stages (AA index [AAI]) at RA, NHF, and O-2). Results: In COPD, sleep apnea improved following O-2 (REM-apnea hypopnea index [AHI] with RA, O-2, and NHF: 18.6 +/- 20.9, 12.7 +/- 18.1, and 14.4 +/- 19.8, respectively; P=0.04 for O-2 and P=0.06 for NHF). REM-AAI was reduced only following NHF in COPD patients (AAI-RA, 21.5 +/- 18.4 n/h and AAI-NHF, 9.9 +/- 6.8 n/h, P=0.02) without changes following O-2 (NFIF-O-2 difference, P=0.01). REM-AAI reduction was associated with lung function expressed as FEV1 and FVC (FEV1: r=-0.59, P=0.001; FEV1/FVC: r=-0.52 and P=0.007). Conclusion: NHF but not elevated oxygenation reduces peripheral vascular sympathetic activity in COPD patients during REM sleep. Sympathetic off-loading by NHF, possibly related to improved breathing mechanics, showed a strong association with COPD severity.
Palavras-chave
COPD, sleep, nasal high flow, oxygen therapy, sympathetic activity, pulse wave amplitude
Referências
- Allen J, 2007, PHYSIOL MEAS, V28, pR1, DOI 10.1088/0967-3334/28/3/R01
- Andreas S, 2003, CHEST, V123, P366, DOI 10.1378/chest.123.2.366
- Ashley C, 2010, J PHYSIOL-LONDON, V588, P701, DOI 10.1113/jphysiol.2009.185348
- Bartels MN, 2004, RESP MED, V98, P84, DOI 10.1016/j.rmed.2002.09.001
- BINI G, 1980, J PHYSIOL-LONDON, V306, P537, DOI 10.1113/jphysiol.1980.sp013413
- Biselli P, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.02251-2017
- Biselli P, 2015, J APPL PHYSIOL, V119, P266, DOI 10.1152/japplphysiol.00455.2014
- Braeunlich J, 2015, MULTIDISCIP RESP MED, V10, DOI 10.1186/s40248-015-0019-y
- Burton AC, 1939, AM J PHYSIOL, V127, P437
- Catcheside PG, 2002, SLEEP, V25, P797, DOI 10.1093/sleep/25.7.797
- Chan GSH, 2012, AM J PHYSIOL-HEART C, V302, pH826, DOI 10.1152/ajpheart.00970.2011
- Chaouat A, 1999, EUR RESPIR J, V14, P1002, DOI 10.1183/09031936.99.14510029
- Clarenbach CF, 2012, HYPERTENS RES, V35, P228, DOI 10.1038/hr.2011.168
- Elgendi M, 2012, CURR CARDIOL REV, V8, P14, DOI 10.2174/157340312801215782
- FLENLEY DC, 1985, CLIN CHEST MED, V6, P651
- FLETCHER EC, 1992, CHEST, V101, P649, DOI 10.1378/chest.101.3.649
- Frat JP, 2015, NEW ENGL J MED, V372, P2185, DOI 10.1056/NEJMoa1503326
- Gottlieb DJ, 2014, NEW ENGL J MED, V370, P2276, DOI 10.1056/NEJMoa1306766
- Grote L, 2003, RESP PHYSIOL NEUROBI, V136, P141, DOI 10.1016/S1569-9048(03)00090-9
- Grote L, 2017, COPD, V14, P565, DOI 10.1080/15412555.2017.1365119
- Grote L, 2011, CHEST, V139, P253, DOI 10.1378/chest.09-3029
- Hedner J, 2011, J CLIN SLEEP MED, V7, P302, DOI 10.5664/JCSM.1078
- Iber C., AASM MANUAL SCORING
- Lewis CA, 2009, THORAX, V64, P133, DOI 10.1136/thx.2007.088930
- Marin JM, 2010, AM J RESP CRIT CARE, V182, P325, DOI 10.1164/rccm.200912-1869OC
- McNicholas WT, 2013, EUR RESPIR REV, V22, P365, DOI 10.1183/09059180.00003213
- Nilius G, 2013, ADV EXP MED BIOL, V755, P27, DOI 10.1007/978-94-007-4546-9_4
- O'Donnell CP, 2002, AM J RESP CRIT CARE, V166, P965, DOI 10.1164/rccm.2110072
- O'Donoghue FJ, 2004, J PHYSIOL-LONDON, V559, P663, DOI 10.1113/jphysiol.204.066084
- O'Donoghue FJ, 2003, EUR RESPIR J, V21, P977, DOI 10.1183/09031936.03.00066802
- Sanders MH, 2003, AM J RESP CRIT CARE, V167, P7, DOI 10.1164/rccm.2203046
- Sommermeyer D, 2016, MED BIOL ENG COMPUT, V54, P1111, DOI 10.1007/s11517-015-1410-8
- Zou D, 2004, SLEEP, V27, P485, DOI 10.1093/sleep/27.3.485
- Zou D, 2010, SLEEP MED, V11, P325, DOI 10.1016/j.sleep.2009.10.004
- Zou D, 2009, SLEEP MED, V10, P836, DOI 10.1016/j.sleep.2008.10.001